BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 12325040)

  • 1. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Shirayama Y; Hashimoto K; Routledge C; Hagan JJ; Ashby CR
    Synapse; 2004 Apr; 52(1):20-8. PubMed ID: 14755629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
    Blackburn TP; Suzuki K; Ashby CR
    Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
    Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K; Suzuki K; McCreary AC; Ashby CR
    Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
    Minabe Y; Matsuno K; Ashby CR
    Synapse; 1999 Aug; 33(2):129-40. PubMed ID: 10400891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the acute and chronic administration of the selective neurokinin2 receptor antagonist SR 48968 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Minabe Y; Ashby CR
    Synapse; 1997 Feb; 25(2):196-204. PubMed ID: 9021900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.
    Pierucci M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 2004 Apr; 309(1):109-18. PubMed ID: 14722316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
    Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
    Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with DAU 6215, a new 5-HT3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic neurons in the rat ventral tegmental area.
    Prisco S; Pessia M; Ceci A; Borsini F; Esposito E
    Eur J Pharmacol; 1992 Apr; 214(1):13-9. PubMed ID: 1582449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y; Emori K; Ashby CR
    Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel atypical antipsychotic cariprazine demonstrates dopamine D
    Delcourte S; Ashby CR; Rovera R; Kiss B; Adham N; Farkas B; Haddjeri N
    CNS Neurosci Ther; 2018 Dec; 24(12):1129-1139. PubMed ID: 29729086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.